These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28441265)

  • 1. Novel Risk Assessment Tool for Immunoglobulin Resistance in Kawasaki Disease: Application Using a Random Forest Classifier.
    Takeuchi M; Inuzuka R; Hayashi T; Shindo T; Hirata Y; Shimizu N; Inatomi J; Yokoyama Y; Namai Y; Oda Y; Takamizawa M; Kagawa J; Harita Y; Oka A
    Pediatr Infect Dis J; 2017 Sep; 36(9):821-826. PubMed ID: 28441265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
    Kanamitsu K; Kakimoto H; Shimada A; Nakata Y; Ochi H; Watanabe H; Iwasaki Y; Tokorodani C; Kanazawa A; Maruyama H; Miyazawa M; Nishiuchi R; Kikkawa K
    Pediatr Int; 2016 Feb; 58(2):146-51. PubMed ID: 26190225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S; Kawashima H; Kashiwagi Y; Hoshika A
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease.
    Joung J; Oh JS; Yoon JM; Ko KO; Yoo GH; Cheon EJ
    BMC Pediatr; 2022 Aug; 22(1):474. PubMed ID: 35931986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
    Durongpisitkul K; Sangtawesin C; Khongphatthanayopthin A; Panamonta M; Sopontammarak S; Sittiwangkul R; Pongpanich B
    Asian Pac J Allergy Immunol; 2006 Mar; 24(1):27-32. PubMed ID: 16913186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q; Gong FQ; Shang SQ; Hu J
    Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an immunoinflammatory indicator-related dynamic nomogram based on machine learning for the prediction of intravenous immunoglobulin-resistant Kawasaki disease patients.
    Wang Y; Cao Y; Li Y; Zhu F; Yuan M; Xu J; Ma X; Li J
    Int Immunopharmacol; 2024 Jun; 134():112194. PubMed ID: 38703570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
    Sánchez-Manubens J; Antón J; Bou R; Iglesias E; Calzada-Hernandez J; Borlan S; Gimenez-Roca C; Rivera J;
    Rheumatol Int; 2016 Jul; 36(7):905-10. PubMed ID: 27215220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
    Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
    Zhang R; Shuai S; Zhang H; Cai J; Cui N; Tang M; Xing S; Gao Y; Liu X; Yang X
    Ital J Pediatr; 2023 Jun; 49(1):78. PubMed ID: 37357258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.
    Tajima M; Shiozawa Y; Kagawa J
    Pediatr Cardiol; 2015 Aug; 36(6):1159-65. PubMed ID: 25753685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
    Lin MT; Chang CH; Sun LC; Liu HM; Chang HW; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
    J Formos Med Assoc; 2016 May; 115(5):350-5. PubMed ID: 25910931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing.
    Yang S; Song R; Zhang J; Li X; Li C
    Arch Dis Child; 2019 Mar; 104(3):262-267. PubMed ID: 30026252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
    Cho HJ; Bak SY; Kim SY; Yoo R; Baek HS; Yang S; Hwang IT; Ban JE
    Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.
    Yanagimoto K; Nomura Y; Masuda K; Hirabayashi M; Morita Y; Yoshishige M; Ueno K; Eguchi T; Kawano Y
    Int Arch Allergy Immunol; 2014; 164(2):83-8. PubMed ID: 24903098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease.
    Qian W; Tang Y; Yan W; Sun L; Lv H
    Ital J Pediatr; 2018 Mar; 44(1):33. PubMed ID: 29523168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.